Financeira Alfa Sa Cred Financ Invest (ex Cia Real Invest Cfi) (CRIV4Q) Quote

https://x.com/KyleClark/status/1835871127752659088


.

Love watching the Christmas movies. We’re getting closer on the new house. They emailed us a tentative closing date for October 25th

Long term outlook puts IFUS on the ground floor.I expect methane emission testing will lead to carbon credits for IFUS and ranchers and dairy farms that use SGP+.Initial testing is leading to new colleges also planning for the future.

https://www.agproud.com/articles/60215-breaking-g

But NO DEBT !

and finished with a whimper

When any merger news happens, Dimartini will be gone.. Could be soon..

Ok, sorry for the misunderstanding.

Conclusion
“In this study, we found five targets of CBD in the treatment of NP with DP.
These findings provide further theoretical and experimental basis for CBD as a potential therapeutic agent.”
https://www.sciencedirect.com/science/article/abs/pii/S0028390824003228

Increases in stock option open interest $INTC $MPW $PLTR $KSS $GOOGL $OPEN $SOFI $PFE $AAPL

Market cap 42 mill about

Increases in stock option open interest $INTC $MPW $PLTR $KSS $GOOGL $OPEN $SOFI $PFE $AAPL

Same. Reloaded .0004's.

Oh wow sure $1.96 per share per year in dividends. This is based on my super flux super capacitor super magnetic super super duper supercharger super conductive super charging super secretive algebraic algorithmic algorithm.

How so when it's public domain now? All RDGL has is a weak process patent and an patent pending for an "improved" application device. Anybody can make a Radiogel offset now. That's what happens when patents expire.

Crazy market cap after that drop

Just watch what we do! Stay tuned.

Clinical trial results expected on September 21st.


https://x.com/kickostocks/status/1835747498507595833?s=46

This recent post from BioElectronics:

The effectiveness of our Model 088 device is backed by a 2015 English scientific study. After a 7-day trial on 5000 patients with severe chronic pain, the majority experienced over a 50% improvement. 2 out of 3 patients reduced or eliminated medic

$SNOA I looked it up https://www.accessdata.fda.gov/scripts/cdrh/devicesatfda/index.cfm?db=pmn&id=K233399

and it was approved on 9/13 510(k) number k233399
Device name: Microdacyn wound care solution

Going to 🩸

Took Profit @10
Good Start ;)

Without a doubt the best kept secret on OTC.
They will most definitely uplist to Nasdaq.
Nothing to stop this from moving to $10 and then likely $15.
Huge potential here. So fortunate to buy some in the $0.60’s months ago. What a steal!!!!!

Looks like old Kim Thompson has finally realized his weekly. PR‘s are hurting the company share price….. he thought he was going to be cute putting out those weekly PR‘s and now we see it stopped … just proves you could only hype something for so long and eventually people catch on to the game. But

Where did they talk about the uplisting? I don’t recall. Was that to QB?

The Old Owl